eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community

All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms   -   Check drugs   -   Compare drugs   -   Join a support group   -   More tools

Review: taking Novantrone and Copaxone together

Summary: drug interactions are reported among people who take Novantrone and Copaxone together.

This review analyzes the effectiveness and drug interactions between Novantrone and Copaxone. It is created by eHealthMe based on reports of 146 people who take the same drugs from FDA and social media, and is updated regularly.


You are not alone: join a support group for people who take Novantrone and Copaxone >>>

On Mar, 3, 2015: 146 people who take Novantrone, Copaxone are studied

Novantrone, Copaxone outcomes

Drug combinations in study:
- Novantrone (mitoxantrone hydrochloride)
- Copaxone (glatiramer acetate)

Drug effectiveness over time :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ yearsnot specified
Novantrone is effectiven/an/an/a100.00%
(1 of 1 people)
Copaxone is effectiven/an/an/an/an/a100.00%
(1 of 1 people)

Drug effectiveness by gender :

Novantrone is effective100.00%
(1 of 1 people)
Copaxone is effective100.00%
(1 of 1 people)

Drug effectiveness by age :

Novantrone is effectiven/an/an/an/a100.00%
(1 of 1 people)
Copaxone is effectiven/an/an/an/a100.00%
(1 of 1 people)

Most common drug interactions over time * :

< 1 month1 - 6 months6 - 12 months1 - 2 years2 - 5 years5 - 10 years10+ yearsnot specified
Cardiac DisorderRenal InsufficiencyStaphylococcal InfectionNauseaLiposarcomaLiposarcoman/aStaphylococcal Infection
Atrial FibrillationRespiratory FailureHeadacheCerebrovascular AccidentRed Blood Cell Count DecreasedBreast CancerNausea
Oedema PeripheralSeptic ShockBladder DisorderCholecystitisAmenorrhoeaVena Cava ThrombosisHeadache
Heart Rate IncreasedStevens Johnson SyndromeAsthmaDeep Vein ThrombosisAcute Promyelocytic LeukaemiaUpper Gastrointestinal HaemorrhageMultiple Sclerosis Relapse
Atrial Pressure IncreasedMyocardial InfarctionUpper Respiratory Tract InfectionHaematuriaVena Cava ThrombosisPancytopeniaAcute Promyelocytic Leukaemia
Cardiac Failure CongestiveHypovolaemic ShockOesophageal CarcinomaAcute Promyelocytic LeukaemiaPremature MenopauseHemiplegiaUpper Respiratory Tract Infection
Pulmonary HypertensionNecrotising FasciitisAccidentOesophageal CarcinomaMetastases To LiverElectrocardiogram AbnormalAcute Myeloid Leukaemia
Pleural EffusionBreast Cancer FemaleMetastases To LiverHaematemesisWhite Blood Cell Count DecreasedCerebrovascular AccidentMyocardial Infarction
Mitral Valve IncompetenceCardiac FailureLiver Function Test AbnormalFatigueSmall Intestine Carcinoma MetastaticAcute Promyelocytic LeukaemiaAsthma
CardiomyopathyLeukopeniaMetastases To BoneMetastases To LiverMetastasisCholecystitisMultiple Sclerosis

Most common drug interactions by gender * :

Staphylococcal InfectionAcute Promyelocytic Leukaemia
HeadacheOesophageal Carcinoma
Bladder DisorderMetastases To Liver
AsthmaMyocardial Infarction
Upper Respiratory Tract InfectionMetastases To Bone
Multiple Sclerosis RelapseCerebrovascular Accident
NauseaWhite Blood Cell Count Decreased
Cardiac FailureConvulsion
Acute Myeloid LeukaemiaCholecystitis

Most common drug interactions by age * :

n/an/an/aMuscle SpasmsStaphylococcal InfectionMyocardial InfarctionOesophageal CarcinomaCardiac Failure
Decubitus UlcerHeadacheNauseaMetastases To LiverPneumonia
CystitisBladder DisorderEjection Fraction DecreasedNauseaMultiple Sclerosis Relapse
B Precursor Type Acute LeukaemiaUpper Respiratory Tract InfectionDeep Vein ThrombosisMetastases To BoneUrinary Tract Infection
Bronchopulmonary AspergillosisAsthmaCholecystitisAcute Promyelocytic LeukaemiaUrosepsis
Back PainAccidentCerebrovascular AccidentMultiple SclerosisColon Cancer
HaemoptysisRoad Traffic AccidentAcute Promyelocytic LeukaemiaHaematuriaInfection Susceptibility Increased
HaematomaMultiple Sclerosis RelapseConvulsionCondition AggravatedLeft Ventricular Dysfunction
Cerebrovascular AccidentGait DisturbanceFatigueSyncopePancreatic Carcinoma

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Novantrone and Copaxone?




You are not alone! Join a related support group:
- support group for people who take Copaxone
- support group for people who take Novantrone

Recent related drug studies (Check your drugs):

Complete drug side effects:

On eHealthMe, Copaxone (glatiramer acetate) is often used to treat multiple sclerosis. Find out below the conditions the drugs are used for, how effective they are, and any alternative drugs that you can use to treat those same conditions.

What is the drug used for and how effective is it:

Other drugs that are used to treat the same conditions:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.


About - Terms of service - Privacy policy - Press - Testimonials - Contact us -

© 2015 All rights reserved. Use of this site constitutes acceptance of's terms of service and privacy policy.